Home > > > > Report Detail

Global Classical Swine Fever Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Publisher Name :
Date: 01-Jan-2023
No. of pages: 110

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).

According to our (Global Info Research) latest study, the global Classical Swine Fever Vaccines market size was valued at USD 183.2 million in 2022 and is forecast to a readjusted size of USD 262.3 million by 2029 with a CAGR of 5.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The global classical swine fever vaccine market is dominated by Winsun, Merial and CAHIC, with the top three manufacturers accounting for about 60% of the market share. Asia Pacific is the largest market for classical swine fever vaccines, with a market share of about 50%, followed by Europe with a market share of about 25%. Tissue Culture Origin is the main type, with a share about 60%. Market Sales is the main application, which holds a share about 95%.

This report is a detailed and comprehensive analysis for global Classical Swine Fever Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Source and by Sales Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Classical Swine Fever Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (US$/K Doses), 2018-2029

Global Classical Swine Fever Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (US$/K Doses), 2018-2029

Global Classical Swine Fever Vaccines market size and forecasts, by Source and by Sales Channel, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (US$/K Doses), 2018-2029

Global Classical Swine Fever Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (US$/K Doses), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Classical Swine Fever Vaccines

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Classical Swine Fever Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include WINSUN, Merial, CAHIC, Chopper Biology and MSD Animal Health (Merck), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

Classical Swine Fever Vaccines market is split by Source and by Sales Channel. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Source, and by Sales Channel in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Source

- Tissue Culture Origin

- Cell Line Origin

Market segment by Sales Channel

- Government Tender

- Market Sales

Major players covered

- WINSUN

- Merial

- CAHIC

- Chopper Biology

- MSD Animal Health (Merck)

- ChengDu Tecbond

- Ceva

- Harbin Veterinary Research Institute

- Qilu Animal Health Products Factory

- Ringpu Biology

- DHN

- CAVAC

- Komipharm

- Agrovet

- Bioveta

- Jinyu Bio-Technology

- Institutul Pasteur

- MVP

- Tecon

Market segment by region, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

- South America (Brazil, Argentina, Colombia, and Rest of South America)

- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Classical Swine Fever Vaccines product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Classical Swine Fever Vaccines, with price, sales, revenue and global market share of Classical Swine Fever Vaccines from 2018 to 2023.

Chapter 3, the Classical Swine Fever Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Classical Swine Fever Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Source and sales channel, with sales market share and growth rate by source, sales channel, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Classical Swine Fever Vaccines market forecast, by regions, source and sales channel, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.

Chapter 13, the key raw materials and key suppliers, and industry chain of Classical Swine Fever Vaccines.

Chapter 14 and 15, to describe Classical Swine Fever Vaccines sales channel, distributors, customers, research findings and conclusion.

Global Classical Swine Fever Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Classical Swine Fever Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Source
1.3.1 Overview: Global Classical Swine Fever Vaccines Consumption Value by Source: 2018 Versus 2022 Versus 2029
1.3.2 Tissue Culture Origin
1.3.3 Cell Line Origin
1.4 Market Analysis by Sales Channel
1.4.1 Overview: Global Classical Swine Fever Vaccines Consumption Value by Sales Channel: 2018 Versus 2022 Versus 2029
1.4.2 Government Tender
1.4.3 Market Sales
1.5 Global Classical Swine Fever Vaccines Market Size & Forecast
1.5.1 Global Classical Swine Fever Vaccines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Classical Swine Fever Vaccines Sales Quantity (2018-2029)
1.5.3 Global Classical Swine Fever Vaccines Average Price (2018-2029)
2 Manufacturers Profiles
2.1 WINSUN
2.1.1 WINSUN Details
2.1.2 WINSUN Major Business
2.1.3 WINSUN Classical Swine Fever Vaccines Product and Services
2.1.4 WINSUN Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 WINSUN Recent Developments/Updates
2.2 Merial
2.2.1 Merial Details
2.2.2 Merial Major Business
2.2.3 Merial Classical Swine Fever Vaccines Product and Services
2.2.4 Merial Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merial Recent Developments/Updates
2.3 CAHIC
2.3.1 CAHIC Details
2.3.2 CAHIC Major Business
2.3.3 CAHIC Classical Swine Fever Vaccines Product and Services
2.3.4 CAHIC Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 CAHIC Recent Developments/Updates
2.4 Chopper Biology
2.4.1 Chopper Biology Details
2.4.2 Chopper Biology Major Business
2.4.3 Chopper Biology Classical Swine Fever Vaccines Product and Services
2.4.4 Chopper Biology Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Chopper Biology Recent Developments/Updates
2.5 MSD Animal Health (Merck)
2.5.1 MSD Animal Health (Merck) Details
2.5.2 MSD Animal Health (Merck) Major Business
2.5.3 MSD Animal Health (Merck) Classical Swine Fever Vaccines Product and Services
2.5.4 MSD Animal Health (Merck) Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 MSD Animal Health (Merck) Recent Developments/Updates
2.6 ChengDu Tecbond
2.6.1 ChengDu Tecbond Details
2.6.2 ChengDu Tecbond Major Business
2.6.3 ChengDu Tecbond Classical Swine Fever Vaccines Product and Services
2.6.4 ChengDu Tecbond Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 ChengDu Tecbond Recent Developments/Updates
2.7 Ceva
2.7.1 Ceva Details
2.7.2 Ceva Major Business
2.7.3 Ceva Classical Swine Fever Vaccines Product and Services
2.7.4 Ceva Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Ceva Recent Developments/Updates
2.8 Harbin Veterinary Research Institute
2.8.1 Harbin Veterinary Research Institute Details
2.8.2 Harbin Veterinary Research Institute Major Business
2.8.3 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product and Services
2.8.4 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Harbin Veterinary Research Institute Recent Developments/Updates
2.9 Qilu Animal Health Products Factory
2.9.1 Qilu Animal Health Products Factory Details
2.9.2 Qilu Animal Health Products Factory Major Business
2.9.3 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product and Services
2.9.4 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Qilu Animal Health Products Factory Recent Developments/Updates
2.10 Ringpu Biology
2.10.1 Ringpu Biology Details
2.10.2 Ringpu Biology Major Business
2.10.3 Ringpu Biology Classical Swine Fever Vaccines Product and Services
2.10.4 Ringpu Biology Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Ringpu Biology Recent Developments/Updates
2.11 DHN
2.11.1 DHN Details
2.11.2 DHN Major Business
2.11.3 DHN Classical Swine Fever Vaccines Product and Services
2.11.4 DHN Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 DHN Recent Developments/Updates
2.12 CAVAC
2.12.1 CAVAC Details
2.12.2 CAVAC Major Business
2.12.3 CAVAC Classical Swine Fever Vaccines Product and Services
2.12.4 CAVAC Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 CAVAC Recent Developments/Updates
2.13 Komipharm
2.13.1 Komipharm Details
2.13.2 Komipharm Major Business
2.13.3 Komipharm Classical Swine Fever Vaccines Product and Services
2.13.4 Komipharm Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Komipharm Recent Developments/Updates
2.14 Agrovet
2.14.1 Agrovet Details
2.14.2 Agrovet Major Business
2.14.3 Agrovet Classical Swine Fever Vaccines Product and Services
2.14.4 Agrovet Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Agrovet Recent Developments/Updates
2.15 Bioveta
2.15.1 Bioveta Details
2.15.2 Bioveta Major Business
2.15.3 Bioveta Classical Swine Fever Vaccines Product and Services
2.15.4 Bioveta Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Bioveta Recent Developments/Updates
2.16 Jinyu Bio-Technology
2.16.1 Jinyu Bio-Technology Details
2.16.2 Jinyu Bio-Technology Major Business
2.16.3 Jinyu Bio-Technology Classical Swine Fever Vaccines Product and Services
2.16.4 Jinyu Bio-Technology Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Jinyu Bio-Technology Recent Developments/Updates
2.17 Institutul Pasteur
2.17.1 Institutul Pasteur Details
2.17.2 Institutul Pasteur Major Business
2.17.3 Institutul Pasteur Classical Swine Fever Vaccines Product and Services
2.17.4 Institutul Pasteur Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Institutul Pasteur Recent Developments/Updates
2.18 MVP
2.18.1 MVP Details
2.18.2 MVP Major Business
2.18.3 MVP Classical Swine Fever Vaccines Product and Services
2.18.4 MVP Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 MVP Recent Developments/Updates
2.19 Tecon
2.19.1 Tecon Details
2.19.2 Tecon Major Business
2.19.3 Tecon Classical Swine Fever Vaccines Product and Services
2.19.4 Tecon Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Tecon Recent Developments/Updates
3 Competitive Environment: Classical Swine Fever Vaccines by Manufacturer
3.1 Global Classical Swine Fever Vaccines Sales Quantity by Manufacturer (2018-2023)
3.2 Global Classical Swine Fever Vaccines Revenue by Manufacturer (2018-2023)
3.3 Global Classical Swine Fever Vaccines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Classical Swine Fever Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Classical Swine Fever Vaccines Manufacturer Market Share in 2022
3.4.2 Top 6 Classical Swine Fever Vaccines Manufacturer Market Share in 2022
3.5 Classical Swine Fever Vaccines Market: Overall Company Footprint Analysis
3.5.1 Classical Swine Fever Vaccines Market: Region Footprint
3.5.2 Classical Swine Fever Vaccines Market: Company Product Type Footprint
3.5.3 Classical Swine Fever Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Classical Swine Fever Vaccines Market Size by Region
4.1.1 Global Classical Swine Fever Vaccines Sales Quantity by Region (2018-2029)
4.1.2 Global Classical Swine Fever Vaccines Consumption Value by Region (2018-2029)
4.1.3 Global Classical Swine Fever Vaccines Average Price by Region (2018-2029)
4.2 North America Classical Swine Fever Vaccines Consumption Value (2018-2029)
4.3 Europe Classical Swine Fever Vaccines Consumption Value (2018-2029)
4.4 Asia-Pacific Classical Swine Fever Vaccines Consumption Value (2018-2029)
4.5 South America Classical Swine Fever Vaccines Consumption Value (2018-2029)
4.6 Middle East and Africa Classical Swine Fever Vaccines Consumption Value (2018-2029)
5 Market Segment by Source
5.1 Global Classical Swine Fever Vaccines Sales Quantity by Source (2018-2029)
5.2 Global Classical Swine Fever Vaccines Consumption Value by Source (2018-2029)
5.3 Global Classical Swine Fever Vaccines Average Price by Source (2018-2029)
6 Market Segment by Sales Channel
6.1 Global Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2018-2029)
6.2 Global Classical Swine Fever Vaccines Consumption Value by Sales Channel (2018-2029)
6.3 Global Classical Swine Fever Vaccines Average Price by Sales Channel (2018-2029)
7 North America
7.1 North America Classical Swine Fever Vaccines Sales Quantity by Source (2018-2029)
7.2 North America Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2018-2029)
7.3 North America Classical Swine Fever Vaccines Market Size by Country
7.3.1 North America Classical Swine Fever Vaccines Sales Quantity by Country (2018-2029)
7.3.2 North America Classical Swine Fever Vaccines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Classical Swine Fever Vaccines Sales Quantity by Source (2018-2029)
8.2 Europe Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2018-2029)
8.3 Europe Classical Swine Fever Vaccines Market Size by Country
8.3.1 Europe Classical Swine Fever Vaccines Sales Quantity by Country (2018-2029)
8.3.2 Europe Classical Swine Fever Vaccines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Classical Swine Fever Vaccines Sales Quantity by Source (2018-2029)
9.2 Asia-Pacific Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2018-2029)
9.3 Asia-Pacific Classical Swine Fever Vaccines Market Size by Region
9.3.1 Asia-Pacific Classical Swine Fever Vaccines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Classical Swine Fever Vaccines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Classical Swine Fever Vaccines Sales Quantity by Source (2018-2029)
10.2 South America Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2018-2029)
10.3 South America Classical Swine Fever Vaccines Market Size by Country
10.3.1 South America Classical Swine Fever Vaccines Sales Quantity by Country (2018-2029)
10.3.2 South America Classical Swine Fever Vaccines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Classical Swine Fever Vaccines Sales Quantity by Source (2018-2029)
11.2 Middle East & Africa Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2018-2029)
11.3 Middle East & Africa Classical Swine Fever Vaccines Market Size by Country
11.3.1 Middle East & Africa Classical Swine Fever Vaccines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Classical Swine Fever Vaccines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Classical Swine Fever Vaccines Market Drivers
12.2 Classical Swine Fever Vaccines Market Restraints
12.3 Classical Swine Fever Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Classical Swine Fever Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Classical Swine Fever Vaccines
13.3 Classical Swine Fever Vaccines Production Process
13.4 Classical Swine Fever Vaccines Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Classical Swine Fever Vaccines Typical Distributors
14.3 Classical Swine Fever Vaccines Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Classical Swine Fever Vaccines Consumption Value by Source, (USD Million), 2018 & 2022 & 2029
Table 2. Global Classical Swine Fever Vaccines Consumption Value by Sales Channel, (USD Million), 2018 & 2022 & 2029
Table 3. WINSUN Basic Information, Manufacturing Base and Competitors
Table 4. WINSUN Major Business
Table 5. WINSUN Classical Swine Fever Vaccines Product and Services
Table 6. WINSUN Classical Swine Fever Vaccines Sales Quantity (M Doses), Average Price (US$/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. WINSUN Recent Developments/Updates
Table 8. Merial Basic Information, Manufacturing Base and Competitors
Table 9. Merial Major Business
Table 10. Merial Classical Swine Fever Vaccines Product and Services
Table 11. Merial Classical Swine Fever Vaccines Sales Quantity (M Doses), Average Price (US$/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Merial Recent Developments/Updates
Table 13. CAHIC Basic Information, Manufacturing Base and Competitors
Table 14. CAHIC Major Business
Table 15. CAHIC Classical Swine Fever Vaccines Product and Services
Table 16. CAHIC Classical Swine Fever Vaccines Sales Quantity (M Doses), Average Price (US$/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. CAHIC Recent Developments/Updates
Table 18. Chopper Biology Basic Information, Manufacturing Base and Competitors
Table 19. Chopper Biology Major Business
Table 20. Chopper Biology Classical Swine Fever Vaccines Product and Services
Table 21. Chopper Biology Classical Swine Fever Vaccines Sales Quantity (M Doses), Average Price (US$/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Chopper Biology Recent Developments/Updates
Table 23. MSD Animal Health (Merck) Basic Information, Manufacturing Base and Competitors
Table 24. MSD Animal Health (Merck) Major Business
Table 25. MSD Animal Health (Merck) Classical Swine Fever Vaccines Product and Services
Table 26. MSD Animal Health (Merck) Classical Swine Fever Vaccines Sales Quantity (M Doses), Average Price (US$/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. MSD Animal Health (Merck) Recent Developments/Updates
Table 28. ChengDu Tecbond Basic Information, Manufacturing Base and Competitors
Table 29. ChengDu Tecbond Major Business
Table 30. ChengDu Tecbond Classical Swine Fever Vaccines Product and Services
Table 31. ChengDu Tecbond Classical Swine Fever Vaccines Sales Quantity (M Doses), Average Price (US$/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. ChengDu Tecbond Recent Developments/Updates
Table 33. Ceva Basic Information, Manufacturing Base and Competitors
Table 34. Ceva Major Business
Table 35. Ceva Classical Swine Fever Vaccines Product and Services
Table 36. Ceva Classical Swine Fever Vaccines Sales Quantity (M Doses), Average Price (US$/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Ceva Recent Developments/Updates
Table 38. Harbin Veterinary Research Institute Basic Information, Manufacturing Base and Competitors
Table 39. Harbin Veterinary Research Institute Major Business
Table 40. Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product and Services
Table 41. Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales Quantity (M Doses), Average Price (US$/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Harbin Veterinary Research Institute Recent Developments/Updates
Table 43. Qilu Animal Health Products Factory Basic Information, Manufacturing Base and Competitors
Table 44. Qilu Animal Health Products Factory Major Business
Table 45. Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product and Services
Table 46. Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales Quantity (M Doses), Average Price (US$/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Qilu Animal Health Products Factory Recent Developments/Updates
Table 48. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 49. Ringpu Biology Major Business
Table 50. Ringpu Biology Classical Swine Fever Vaccines Product and Services
Table 51. Ringpu Biology Classical Swine Fever Vaccines Sales Quantity (M Doses), Average Price (US$/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Ringpu Biology Recent Developments/Updates
Table 53. DHN Basic Information, Manufacturing Base and Competitors
Table 54. DHN Major Business
Table 55. DHN Classical Swine Fever Vaccines Product and Services
Table 56. DHN Classical Swine Fever Vaccines Sales Quantity (M Doses), Average Price (US$/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. DHN Recent Developments/Updates
Table 58. CAVAC Basic Information, Manufacturing Base and Competitors
Table 59. CAVAC Major Business
Table 60. CAVAC Classical Swine Fever Vaccines Product and Services
Table 61. CAVAC Classical Swine Fever Vaccines Sales Quantity (M Doses), Average Price (US$/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. CAVAC Recent Developments/Updates
Table 63. Komipharm Basic Information, Manufacturing Base and Competitors
Table 64. Komipharm Major Business
Table 65. Komipharm Classical Swine Fever Vaccines Product and Services
Table 66. Komipharm Classical Swine Fever Vaccines Sales Quantity (M Doses), Average Price (US$/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Komipharm Recent Developments/Updates
Table 68. Agrovet Basic Information, Manufacturing Base and Competitors
Table 69. Agrovet Major Business
Table 70. Agrovet Classical Swine Fever Vaccines Product and Services
Table 71. Agrovet Classical Swine Fever Vaccines Sales Quantity (M Doses), Average Price (US$/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Agrovet Recent Developments/Updates
Table 73. Bioveta Basic Information, Manufacturing Base and Competitors
Table 74. Bioveta Major Business
Table 75. Bioveta Classical Swine Fever Vaccines Product and Services
Table 76. Bioveta Classical Swine Fever Vaccines Sales Quantity (M Doses), Average Price (US$/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Bioveta Recent Developments/Updates
Table 78. Jinyu Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 79. Jinyu Bio-Technology Major Business
Table 80. Jinyu Bio-Technology Classical Swine Fever Vaccines Product and Services
Table 81. Jinyu Bio-Technology Classical Swine Fever Vaccines Sales Quantity (M Doses), Average Price (US$/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Jinyu Bio-Technology Recent Developments/Updates
Table 83. Institutul Pasteur Basic Information, Manufacturing Base and Competitors
Table 84. Institutul Pasteur Major Business
Table 85. Institutul Pasteur Classical Swine Fever Vaccines Product and Services
Table 86. Institutul Pasteur Classical Swine Fever Vaccines Sales Quantity (M Doses), Average Price (US$/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Institutul Pasteur Recent Developments/Updates
Table 88. MVP Basic Information, Manufacturing Base and Competitors
Table 89. MVP Major Business
Table 90. MVP Classical Swine Fever Vaccines Product and Services
Table 91. MVP Classical Swine Fever Vaccines Sales Quantity (M Doses), Average Price (US$/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. MVP Recent Developments/Updates
Table 93. Tecon Basic Information, Manufacturing Base and Competitors
Table 94. Tecon Major Business
Table 95. Tecon Classical Swine Fever Vaccines Product and Services
Table 96. Tecon Classical Swine Fever Vaccines Sales Quantity (M Doses), Average Price (US$/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Tecon Recent Developments/Updates
Table 98. Global Classical Swine Fever Vaccines Sales Quantity by Manufacturer (2018-2023) & (M Doses)
Table 99. Global Classical Swine Fever Vaccines Revenue by Manufacturer (2018-2023) & (USD Million)
Table 100. Global Classical Swine Fever Vaccines Average Price by Manufacturer (2018-2023) & (US$/K Doses)
Table 101. Market Position of Manufacturers in Classical Swine Fever Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 102. Head Office and Classical Swine Fever Vaccines Production Site of Key Manufacturer
Table 103. Classical Swine Fever Vaccines Market: Company Product Type Footprint
Table 104. Classical Swine Fever Vaccines Market: Company Product Application Footprint
Table 105. Classical Swine Fever Vaccines New Market Entrants and Barriers to Market Entry
Table 106. Classical Swine Fever Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 107. Global Classical Swine Fever Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
Table 108. Global Classical Swine Fever Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
Table 109. Global Classical Swine Fever Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 110. Global Classical Swine Fever Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 111. Global Classical Swine Fever Vaccines Average Price by Region (2018-2023) & (US$/K Doses)
Table 112. Global Classical Swine Fever Vaccines Average Price by Region (2024-2029) & (US$/K Doses)
Table 113. Global Classical Swine Fever Vaccines Sales Quantity by Source (2018-2023) & (M Doses)
Table 114. Global Classical Swine Fever Vaccines Sales Quantity by Source (2024-2029) & (M Doses)
Table 115. Global Classical Swine Fever Vaccines Consumption Value by Source (2018-2023) & (USD Million)
Table 116. Global Classical Swine Fever Vaccines Consumption Value by Source (2024-2029) & (USD Million)
Table 117. Global Classical Swine Fever Vaccines Average Price by Source (2018-2023) & (US$/K Doses)
Table 118. Global Classical Swine Fever Vaccines Average Price by Source (2024-2029) & (US$/K Doses)
Table 119. Global Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2018-2023) & (M Doses)
Table 120. Global Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2024-2029) & (M Doses)
Table 121. Global Classical Swine Fever Vaccines Consumption Value by Sales Channel (2018-2023) & (USD Million)
Table 122. Global Classical Swine Fever Vaccines Consumption Value by Sales Channel (2024-2029) & (USD Million)
Table 123. Global Classical Swine Fever Vaccines Average Price by Sales Channel (2018-2023) & (US$/K Doses)
Table 124. Global Classical Swine Fever Vaccines Average Price by Sales Channel (2024-2029) & (US$/K Doses)
Table 125. North America Classical Swine Fever Vaccines Sales Quantity by Source (2018-2023) & (M Doses)
Table 126. North America Classical Swine Fever Vaccines Sales Quantity by Source (2024-2029) & (M Doses)
Table 127. North America Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2018-2023) & (M Doses)
Table 128. North America Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2024-2029) & (M Doses)
Table 129. North America Classical Swine Fever Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
Table 130. North America Classical Swine Fever Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
Table 131. North America Classical Swine Fever Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 132. North America Classical Swine Fever Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Europe Classical Swine Fever Vaccines Sales Quantity by Source (2018-2023) & (M Doses)
Table 134. Europe Classical Swine Fever Vaccines Sales Quantity by Source (2024-2029) & (M Doses)
Table 135. Europe Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2018-2023) & (M Doses)
Table 136. Europe Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2024-2029) & (M Doses)
Table 137. Europe Classical Swine Fever Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
Table 138. Europe Classical Swine Fever Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
Table 139. Europe Classical Swine Fever Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 140. Europe Classical Swine Fever Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 141. Asia-Pacific Classical Swine Fever Vaccines Sales Quantity by Source (2018-2023) & (M Doses)
Table 142. Asia-Pacific Classical Swine Fever Vaccines Sales Quantity by Source (2024-2029) & (M Doses)
Table 143. Asia-Pacific Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2018-2023) & (M Doses)
Table 144. Asia-Pacific Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2024-2029) & (M Doses)
Table 145. Asia-Pacific Classical Swine Fever Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
Table 146. Asia-Pacific Classical Swine Fever Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
Table 147. Asia-Pacific Classical Swine Fever Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 148. Asia-Pacific Classical Swine Fever Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 149. South America Classical Swine Fever Vaccines Sales Quantity by Source (2018-2023) & (M Doses)
Table 150. South America Classical Swine Fever Vaccines Sales Quantity by Source (2024-2029) & (M Doses)
Table 151. South America Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2018-2023) & (M Doses)
Table 152. South America Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2024-2029) & (M Doses)
Table 153. South America Classical Swine Fever Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
Table 154. South America Classical Swine Fever Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
Table 155. South America Classical Swine Fever Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 156. South America Classical Swine Fever Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 157. Middle East & Africa Classical Swine Fever Vaccines Sales Quantity by Source (2018-2023) & (M Doses)
Table 158. Middle East & Africa Classical Swine Fever Vaccines Sales Quantity by Source (2024-2029) & (M Doses)
Table 159. Middle East & Africa Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2018-2023) & (M Doses)
Table 160. Middle East & Africa Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2024-2029) & (M Doses)
Table 161. Middle East & Africa Classical Swine Fever Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
Table 162. Middle East & Africa Classical Swine Fever Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
Table 163. Middle East & Africa Classical Swine Fever Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 164. Middle East & Africa Classical Swine Fever Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 165. Classical Swine Fever Vaccines Raw Material
Table 166. Key Manufacturers of Classical Swine Fever Vaccines Raw Materials
Table 167. Classical Swine Fever Vaccines Typical Distributors
Table 168. Classical Swine Fever Vaccines Typical Customers
List of Figures
Figure 1. Classical Swine Fever Vaccines Picture
Figure 2. Global Classical Swine Fever Vaccines Consumption Value by Source, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Classical Swine Fever Vaccines Consumption Value Market Share by Source in 2022
Figure 4. Tissue Culture Origin Examples
Figure 5. Cell Line Origin Examples
Figure 6. Global Classical Swine Fever Vaccines Consumption Value by Sales Channel, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Classical Swine Fever Vaccines Consumption Value Market Share by Sales Channel in 2022
Figure 8. Government Tender Examples
Figure 9. Market Sales Examples
Figure 10. Global Clas
  • Global Classical Swine Fever Vaccines Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100
    It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......
  • Global Tylosin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......
  • Global Animal Parasiticides Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106
    According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......
  • Global Newcastle Disease Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......
  • Global Classical Swine Fever Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126
    According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......
  • Global Veterinary Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151
    According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......
  • Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......
  • Global Veterinary Products for Companion Animals Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......
  • Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115
    According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs